flow trial semaglutide kidney outcomes hazard ratio 0.76 FLOWing with the — NephJC Effects of Once-Weekly Semaglutide on

95% CI 0.760.92) and the risk of non-fatal stroke by 16% (HR = 0.84

Heres what the science says

This advanced dual-peptide topical cream combines the skin-renewing benefits of GHK-Cu (Copper Peptide) with the regenerative and tissue-supporting properties of BPC-157 to help promote healthier, stronger, and more resilient skin

Although the relative increase appears significant, the condition itself remains uncommon, which is why ophthalmologists focus on early recognition and prompt assessment rather than avoidance of an otherwise valuable treatment

Some researchers include both BPC-157 and copper peptides in their protocols, reasoning that systemic healing support from BPC-157 complements the local follicle support from topical AHK-Cu

The full semaglutide conversion chart covers additional concentrations and edge cases